http://researchonline.federation.edu.au/vital/access/manager/Index ${session.getAttribute("locale")} 5 Paclitaxel-induced Src activation is inhibited by dasatinib treatment, independently of cancer stem cell properties, in a mouse model of ovarian cancer http://researchonline.federation.edu.au/vital/access/manager/Repository/vital:13849 Wed 07 Apr 2021 14:01:57 AEST ]]> Momelotinib decreased cancer stem cell associated tumor burden and prolonged disease-free remission period in a mouse model of human ovarian cancer http://researchonline.federation.edu.au/vital/access/manager/Repository/vital:13084 Wed 07 Apr 2021 14:01:16 AEST ]]> Knockdown of stem cell regulator Oct4A in ovarian cancer reveals cellular reprogramming associated with key regulators of cytoskeleton-extracellular matrix remodelling http://researchonline.federation.edu.au/vital/access/manager/Repository/vital:11406 Wed 07 Apr 2021 13:56:43 AEST ]]> Coalition of Oct4A and β1 integrins in facilitating metastasis in ovarian cancer http://researchonline.federation.edu.au/vital/access/manager/Repository/vital:10794 Wed 07 Apr 2021 13:56:09 AEST ]]>